{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:02:50Z","timestamp":1759104170470,"version":"3.44.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.vetimm.2023.110647","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T20:40:01Z","timestamp":1692996001000},"page":"110647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Significant increase in MIC-A and MIC-B and soluble MIC-A and MIC-B in canine lymphomas"],"prefix":"10.1016","volume":"264","author":[{"given":"Maresa","family":"Lopez-Monta\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Jimenez-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa Rocio","family":"Cruz-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Gabriel","family":"Hernandez-Chavez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Arcelia","family":"Montiel-Cervantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elba","family":"Reyes-Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8070-0415","authenticated-orcid":false,"given":"Jorge","family":"Vela-Ojeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vetimm.2023.110647_bib1","first-page":"141","article-title":"Estudio histol\u00f3gico e inmunofenot\u00edpico de linfoma canino en el centro de M\u00e9xico","volume":"40","author":"\u00c1lvarez","year":"2009","journal-title":"Vet. Mex."},{"issue":"2","key":"10.1016\/j.vetimm.2023.110647_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/0008-5472.CAN-09-1688","article-title":"Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes","volume":"70","author":"Ashiru","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.vetimm.2023.110647_bib3","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2015.52","article-title":"Nasal NK\/T-Cell lymphoma. A comparative analysis of a Mexican population with the other populations of Latin-America","volume":"7","author":"Aviles","year":"2015","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.vetimm.2023.110647_bib4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fimmu.2019.00909","article-title":"The natural cytotoxicity receptors in health and disease","volume":"10","author":"Barrow","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vetimm.2023.110647_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.0300-9475.2004.01475.x","article-title":"Activation of natural killer cells: underlying molecular mechanisms revealed","volume":"60","author":"Backstrom","year":"2004","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"10.1016\/j.vetimm.2023.110647_bib6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cvsm.2019.04.010","article-title":"Cancer Immunotherapies","volume":"49","author":"Bergman","year":"2019","journal-title":"Vet. Clin. North. Am. Small Anim. Pract."},{"issue":"1","key":"10.1016\/j.vetimm.2023.110647_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2005-04-1351","article-title":"Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion","volume":"107","author":"Bryceson","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.vetimm.2023.110647_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40425-017-0305-7","article-title":"Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial","volume":"5","author":"Canter","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.vetimm.2023.110647_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/icb.2016.2","article-title":"A short half-life of ULBP1 at the cell surface due to internalization and proteosomal degradation","volume":"94","author":"Fern\u00e1ndez-Messina","year":"2016","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.vetimm.2023.110647_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/0300985812465325","article-title":"Molecular profiling reveals prognostically significant subtypes of canine lymphoma","volume":"50","author":"Frantz","year":"2012","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2023.110647_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fimmu.2016.00521","article-title":"NCR1 Expression identifies canine natural killer cell subsets with phenotypic similarity to human natural killer cells","volume":"7","author":"Foltz","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vetimm.2023.110647_bib12","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/bjc.2017.79","article-title":"MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumors and normal tissue","volume":"116","author":"Ghadially","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.vetimm.2023.110647_bib13","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3390\/jcm8111802","article-title":"Characterization and potential applications of dog natural killer cells in cancer immunotherapy","volume":"8","author":"Gingrich","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.vetimm.2023.110647_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11259-014-9624-z","article-title":"NCR1+ cells in dogs show phenotypic characteristics of natural killer cells","volume":"39","author":"Gr\u00f8ndahl-Rosado","year":"2014","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.vetimm.2023.110647_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.vetimm.2016.05.001","article-title":"NCR1 is an activating receptor expressed on a subset of canine NK cells","volume":"177","author":"Gr\u00f8ndahl-Rosado","year":"2016","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2023.110647_bib16","first-page":"230","article-title":"Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II","volume":"16","author":"Herberman","year":"1975","journal-title":"Charact. Eff. Cells Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.vetimm.2023.110647_bib17","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s00262-006-0167-1","article-title":"Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA","volume":"55","author":"Holdenrieder","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.vetimm.2023.110647_bib18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1189\/jlb.71.6.907","article-title":"Immune escape of tumors: apoptosis resistance and tumor counterattack","volume":"71","author":"Igney","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.vetimm.2023.110647_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.vetimm.2014.02.016","article-title":"Canine lymphoma as comparative model for human non-Hodgkin lymphoma: recent progress and applications","volume":"159","author":"Ito","year":"2014","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"3","key":"10.1016\/j.vetimm.2023.110647_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1590\/1678-4162-11484","article-title":"Histopathological and immunophenotypical characterization of canine multicentric lymphoma in Brazil: a study of 203 cases","volume":"72","author":"Jark","year":"2020","journal-title":"Arq. Bras. Med. Vet. Zoot."},{"issue":"2","key":"10.1016\/j.vetimm.2023.110647_bib21","first-page":"2389","article-title":"Case Report Diagnosis and pathological characteristics of canine lymphoma: report of 4 cases","volume":"9","author":"Jia","year":"2016","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.vetimm.2023.110647_bib22","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/annonc\/mds171","article-title":"Menstrual and reproductive factors, and hormonal contraception use: association with non-Hodgkin lymphoma in a pooled analysis of interLymph case-control studies","volume":"23","author":"Kane","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.vetimm.2023.110647_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/eji.1830050208","article-title":"Natural\u201d killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.vetimm.2023.110647_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer immunol. Res."},{"key":"10.1016\/j.vetimm.2023.110647_bib25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3389\/fimmu.2018.00841","article-title":"Comparison of phenotypic and functional characteristics between canine non-B, non-T natural killer lymphocytes and CD3+CD5dimCD21\u2212 cytotoxic large granular lymphocytes","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vetimm.2023.110647_bib26","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.28775","article-title":"NKG2D signaling in cancer immunosurveillance","volume":"136","author":"Lopez-Soto","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.vetimm.2023.110647_bib27","doi-asserted-by":"crossref","unstructured":"Mendoza Rinc\u00f3n, Jorge Flavio. 2014. El receptor NKG2D en la frontera de la inmunovigilancia y la carcinog\u00e9nesis. Nova 12(21), 37\u201343. \u3008http:\/\/www.scielo.org.co\/scielo.php?script=sci_arttext&pid=S1794\u201324702014000100003&lng=en&tlng=es\u3009. (17 July 2023).","DOI":"10.22490\/24629448.994"},{"issue":"3","key":"10.1016\/j.vetimm.2023.110647_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.vetimm.2013.06.013","article-title":"Isolation and characterization of canine natural killer cells","volume":"155","author":"Michael","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2023.110647_bib29","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1158\/0008-5472.CAN-04-4613","article-title":"Distinct B-cells and T-cells lymphoproliferative disease prevalence among dog breeds indicates heritable risk","volume":"65","author":"Modiano","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.vetimm.2023.110647_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/vr.103456","article-title":"Treatment of T cell lymphoma in dogs","volume":"179","author":"Moore","year":"2016","journal-title":"Vet. Rec."},{"issue":"1","key":"10.1016\/j.vetimm.2023.110647_bib31","first-page":"47","article-title":"C\u00e9lulas NK: generalidades y papel durante la infecci\u00f3n por el virus de la inmunodeficiencia humana tipo 1 (VIH-1). Iatreia","volume":"20","author":"Moreno Fern\u00e1ndez","year":"2007"},{"key":"10.1016\/j.vetimm.2023.110647_bib32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1146\/annurev.immunol.20.100301.064812","article-title":"Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination","volume":"20","author":"Natarajan","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"suppl 1","key":"10.1016\/j.vetimm.2023.110647_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/vco.12112","article-title":"Immunophenotypic characterization of canine malignant lymphoma: a retrospective study of cases diagnosed in Poland Lower Silesia over the period 2011-2013","volume":"14","author":"Pawlak","year":"2016","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2023.110647_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tvjl.2019.01.003","article-title":"Incidence, characteristics and geographical distributions of canine and human non-Hodgkin's lymphoma in the Porto region (North West Portugal)","volume":"245","author":"Pinello","year":"2019","journal-title":"Vet. J."},{"key":"10.1016\/j.vetimm.2023.110647_bib35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0300985810363902","article-title":"A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology","volume":"47","author":"Ponce","year":"2010","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2023.110647_bib36","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/eji.202049028","article-title":"Human NK cells, their receptors and function","volume":"51","author":"Quatrini","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.vetimm.2023.110647_bib37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1593\/neo.04316","article-title":"Downregulation and\/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma","volume":"6","author":"Raffaghello","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.vetimm.2023.110647_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.vetimm.2023.110647_bib39","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/vco.12258","article-title":"Differences in the geographic distribution of lymphoma subtypes in Golden retrievers in the USA","volume":"15","author":"Ruple","year":"2016","journal-title":"Vet. Comp. Oncol."},{"issue":"2","key":"10.1016\/j.vetimm.2023.110647_bib40","first-page":"169","article-title":"Immunophenotypic characterization of canine lymphoproliferative disorders","volume":"11","author":"Ruslander","year":"1997","journal-title":"In Vivo"},{"key":"10.1016\/j.vetimm.2023.110647_bib41","doi-asserted-by":"crossref","DOI":"10.22201\/fmvz.24486760e.2019.2.495","article-title":"Canine lymphoma: pathological and clinical characteristics of patients treated at a referral hospital","author":"Sanchez","year":"2019","journal-title":"Vet. Mex."},{"issue":"12","key":"10.1016\/j.vetimm.2023.110647_bib42","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4067\/S0034-98872000001200009","article-title":"Celulas natural killer y el sistema inmune innato en la patolog\u00eda infecciosa","volume":"128","author":"Sep\u00falveda C","year":"2000","journal-title":"Rev. Med. Chile"},{"key":"10.1016\/j.vetimm.2023.110647_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.vetimm.2013.03.006","article-title":"Ex vivo expansion of canine cytotoxic large granular exhibiting characteristics of natural killer cells","volume":"153","author":"Shin","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2023.110647_bib44","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., Vardiman, J.W., 2008. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues,\u00a0fourth ed,\u00a0International Agency for Research on Cancer, Lyon, 2, 82\u201384, ."},{"key":"10.1016\/j.vetimm.2023.110647_bib45","unstructured":"Vail, D.M., Pinkerton, M.E., Young, K.M. 2012. Canine Lymphoma and Lymphoid Leukemia, fifth ed, Withrow and MacEwen's Small Animal Clinical Oncology, 608\u2013638."},{"key":"10.1016\/j.vetimm.2023.110647_bib46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/0300985813478210","article-title":"Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival","volume":"50","author":"Valli","year":"2013","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2023.110647_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0300985810379428","article-title":"Classification of canine malignant lymphoma according to the world health organization criteria","volume":"48","author":"Valli","year":"2011","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2023.110647_bib48","series-title":"Kennedy & Palmer's Pathology of Domestic Animals","first-page":"102","article-title":"Hematopoietic system. Jubb","author":"Valli","year":"2015"},{"key":"10.1016\/j.vetimm.2023.110647_bib49","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/10428194.2020.1852473","article-title":"Clinical relevance of NKT cells and soluble MIC-A in Hodgkin lymphoma","volume":"62","author":"Vela-Ojeda","year":"2021","journal-title":"Leuk. Lymph."},{"key":"10.1016\/j.vetimm.2023.110647_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/591753","article-title":"Hormonal and sex impact on the epidemiology of canine lymphoma","author":"Villamil","year":"2009","journal-title":"J. Cancer Epidemiol."},{"issue":"Suppl","key":"10.1016\/j.vetimm.2023.110647_bib51","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: Mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.vetimm.2023.110647_bib52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/01652176.2016.1152633","article-title":"Canine lymphoma: a review","volume":"36","author":"Zandvliet","year":"2016","journal-title":"Vet. Q."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242723001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242723001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:29:21Z","timestamp":1759044561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242723001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":52,"alternative-id":["S0165242723001010"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2023.110647","relation":{},"ISSN":["0165-2427"],"issn-type":[{"type":"print","value":"0165-2427"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significant increase in MIC-A and MIC-B and soluble MIC-A and MIC-B in canine lymphomas","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2023.110647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110647"}}